Can we see some ID, please?

You must be of legal age in your province of residence to enter our website.

Untitled | Lift & Co. Cannabis Expo

Jan 11

08:00am - 09:00am

Registration & Breakfast

09:00am - 09:10am

Welcome Remarks

Forecast overview of the global cannabis spend opportunity, including -
  • Growth forecast and analysis, major geographies
  • Key market trends
  • Industry Review (top verticals making a play in the cannabis space)
  • Top global and regional players in the cannabis ecosystem
  • Promising new entrants
Canada’s population is one-tenth of the U.S., and we’re known to be far less aggressively competitive. Can Canada use its first-mover advantage to tap into the world’s largest consumer economy, or will we be consumed by it? Hear experts debate both sides on whether Canada will emerge on top, or lose its competitive advantage to the immense brand power of the U.S. Learn about the opportunities and challenges a legal U.S. market represents, what early movers such as California and Colorado can teach us, how Canada can distinguish itself as a leader and emulate successful consumer packaged goods markets.
10:30am - 11:00am

Networking Break

Europe is a complex market, with 28 member countries in the European Union that each have differing laws and policies around medical and recreational cannabis. With a population of more than double the United States and Canada, the EU has big market potential but it’s also challenging. In this panel, learn about the next medical and recreational cannabis markets set to come online with a country-by-country overview of the state of industry regulations. Hear from successful Canadian business leaders on navigating foreign bureaucracies, regulatory agencies and distribution points, raising and investing capital, and preparing forward-looking strategies. Learn about business and investment opportunities and scaling in an emerging market that doesn’t have a harmonized approach.
12:00pm - 1:30pm

Lunch

This year’s introduction of new product classes represents a second market launch, the evolution from an industry focused on plant matter to that of one centred around processed consumer goods. Panelists will examine how licensees are planning for new operational infrastructure, establishing research & development capabilities, and devising incisive go-to-market strategies. This will include the dichotomous balance between amassing the institutional knowledge internally and relying on the expertise of strategic partners, such as food and beverage manufacturers.
The increased market opportunities created by legalization have opened up more  funding for research. Join us for a look at the latest research happening in Canada around medical applications and potential benefits, risks for young people, and how Canadian LPs are exporting to the U.S. for research. Will the list of medical cannabis uses decrease, and what does the Cannabis Act replacing the ACMPR mean for patients? What are the implications if employers/insurers start paying for medical cannabis?
3:00pm - 3:30pm

Networking Break

Provincial oversight of cannabis retail has resulted in widely different regional approaches. In this critical look at the future of Canadian cannabis retail, we’ll hear from national leaders of successful chains on the pros and cons of being full-service vs. specialized and how to stay agile amid changing legislation, taxation and customer preferences. As new product categories come on stream, learn about cross-sector integration when edibles, beverages, concentrates and topicals. Plus, what can cannabis learn from other sectors such as alcohol?
5:00pm - 7:00pm

Networking Reception

Alex Shiff

Senior Consultant, Navigator

Andrés Fajardo

Co-Founder and Chairman, Clever Leaves

Brian Harriman

President & CEO, Alcool NB Liquor

Cameron Bishop

Canadian Government Affairs Activities, Tilray Inc., Privateer Holdings

Chris Friel

Mayor, City of Brantford

Chuck Rifici

Chairman and CEO, Cannabis Wheaton Income

Dan Sutton

CEO and Founder, Tantalus Labs

Dr. Arup Sen

CEO, Infusion Biosciences

Dr. Danial Schecter

Founder, Cannabinoid Medical Clinic

Dr. Jonathan Page

CEO and Co-Founder, Anandia Labs

Dr. Natasha Ryz

CSO, Zenabis

Eric Costen

Director General, Cannabis Legalization and Regulation Secretariat, Government of Canada

Felicia Snyder

SVP of Growth, Hiku Brands

Hugo Alves

President & Director, Wheaton Income

Jim Carmack

Head of Capital Markets, MedMen Enterprises

John Clare

Director of Policy, Cannabis Legalization Regulation Secretariat, Government of Canada

John Kagia

EVP, Industry Analytics, New Frontier Data

Justin Bates

CEO, Neighbourhood Pharmacy Association of Canada

Loren Padelford

VP, Shopify

Louis Barre

Principal, Cannab Intel Inc.

Jan 12

08:00am - 09:00am

Registration & Breakfast

09:00am - 09:10am

Welcome Remarks

Forecast overview of the global cannabis spend opportunity, including -
  • Growth forecast and analysis, major geographies
  • Key market trends
  • Industry Review (top verticals making a play in the cannabis space)
  • Top global and regional players in the cannabis ecosystem
  • Promising new entrants
Canada’s population is one-tenth of the U.S., and we’re known to be far less aggressively competitive. Can Canada use its first-mover advantage to tap into the world’s largest consumer economy, or will we be consumed by it? Hear experts debate both sides on whether Canada will emerge on top, or lose its competitive advantage to the immense brand power of the U.S. Learn about the opportunities and challenges a legal U.S. market represents, what early movers such as California and Colorado can teach us, how Canada can distinguish itself as a leader and emulate successful consumer packaged goods markets.
10:30am - 11:00am

Networking Break

Europe is a complex market, with 28 member countries in the European Union that each have differing laws and policies around medical and recreational cannabis. With a population of more than double the United States and Canada, the EU has big market potential but it’s also challenging. In this panel, learn about the next medical and recreational cannabis markets set to come online with a country-by-country overview of the state of industry regulations. Hear from successful Canadian business leaders on navigating foreign bureaucracies, regulatory agencies and distribution points, raising and investing capital, and preparing forward-looking strategies. Learn about business and investment opportunities and scaling in an emerging market that doesn’t have a harmonized approach.
12:00pm - 1:30pm

Lunch

This year’s introduction of new product classes represents a second market launch, the evolution from an industry focused on plant matter to that of one centred around processed consumer goods. Panelists will examine how licensees are planning for new operational infrastructure, establishing research & development capabilities, and devising incisive go-to-market strategies. This will include the dichotomous balance between amassing the institutional knowledge internally and relying on the expertise of strategic partners, such as food and beverage manufacturers.
The increased market opportunities created by legalization have opened up more  funding for research. Join us for a look at the latest research happening in Canada around medical applications and potential benefits, risks for young people, and how Canadian LPs are exporting to the U.S. for research. Will the list of medical cannabis uses decrease, and what does the Cannabis Act replacing the ACMPR mean for patients? What are the implications if employers/insurers start paying for medical cannabis?
3:00pm - 3:30pm

Networking Break

Provincial oversight of cannabis retail has resulted in widely different regional approaches. In this critical look at the future of Canadian cannabis retail, we’ll hear from national leaders of successful chains on the pros and cons of being full-service vs. specialized and how to stay agile amid changing legislation, taxation and customer preferences. As new product categories come on stream, learn about cross-sector integration when edibles, beverages, concentrates and topicals. Plus, what can cannabis learn from other sectors such as alcohol?
5:00pm - 7:00pm

Networking Reception

Alex Shiff

Senior Consultant, Navigator

Andrés Fajardo

Co-Founder and Chairman, Clever Leaves

Brian Harriman

President & CEO, Alcool NB Liquor

Cameron Bishop

Canadian Government Affairs Activities, Tilray Inc., Privateer Holdings

Chris Friel

Mayor, City of Brantford

Chuck Rifici

Chairman and CEO, Cannabis Wheaton Income

Dan Sutton

CEO and Founder, Tantalus Labs

Dr. Arup Sen

CEO, Infusion Biosciences

Dr. Danial Schecter

Founder, Cannabinoid Medical Clinic

Dr. Jonathan Page

CEO and Co-Founder, Anandia Labs

Dr. Natasha Ryz

CSO, Zenabis

Eric Costen

Director General, Cannabis Legalization and Regulation Secretariat, Government of Canada

Felicia Snyder

SVP of Growth, Hiku Brands

Hugo Alves

President & Director, Wheaton Income

Jim Carmack

Head of Capital Markets, MedMen Enterprises

John Clare

Director of Policy, Cannabis Legalization Regulation Secretariat, Government of Canada

John Kagia

EVP, Industry Analytics, New Frontier Data

Justin Bates

CEO, Neighbourhood Pharmacy Association of Canada

Loren Padelford

VP, Shopify

Louis Barre

Principal, Cannab Intel Inc.

Jan 13

08:00am - 09:00am

Registration & Breakfast

09:00am - 09:10am

Welcome Remarks

Forecast overview of the global cannabis spend opportunity, including -
  • Growth forecast and analysis, major geographies
  • Key market trends
  • Industry Review (top verticals making a play in the cannabis space)
  • Top global and regional players in the cannabis ecosystem
  • Promising new entrants
Canada’s population is one-tenth of the U.S., and we’re known to be far less aggressively competitive. Can Canada use its first-mover advantage to tap into the world’s largest consumer economy, or will we be consumed by it? Hear experts debate both sides on whether Canada will emerge on top, or lose its competitive advantage to the immense brand power of the U.S. Learn about the opportunities and challenges a legal U.S. market represents, what early movers such as California and Colorado can teach us, how Canada can distinguish itself as a leader and emulate successful consumer packaged goods markets.
10:30am - 11:00am

Networking Break

Europe is a complex market, with 28 member countries in the European Union that each have differing laws and policies around medical and recreational cannabis. With a population of more than double the United States and Canada, the EU has big market potential but it’s also challenging. In this panel, learn about the next medical and recreational cannabis markets set to come online with a country-by-country overview of the state of industry regulations. Hear from successful Canadian business leaders on navigating foreign bureaucracies, regulatory agencies and distribution points, raising and investing capital, and preparing forward-looking strategies. Learn about business and investment opportunities and scaling in an emerging market that doesn’t have a harmonized approach.
12:00pm - 1:30pm

Lunch

This year’s introduction of new product classes represents a second market launch, the evolution from an industry focused on plant matter to that of one centred around processed consumer goods. Panelists will examine how licensees are planning for new operational infrastructure, establishing research & development capabilities, and devising incisive go-to-market strategies. This will include the dichotomous balance between amassing the institutional knowledge internally and relying on the expertise of strategic partners, such as food and beverage manufacturers.
The increased market opportunities created by legalization have opened up more  funding for research. Join us for a look at the latest research happening in Canada around medical applications and potential benefits, risks for young people, and how Canadian LPs are exporting to the U.S. for research. Will the list of medical cannabis uses decrease, and what does the Cannabis Act replacing the ACMPR mean for patients? What are the implications if employers/insurers start paying for medical cannabis?
3:00pm - 3:30pm

Networking Break

Provincial oversight of cannabis retail has resulted in widely different regional approaches. In this critical look at the future of Canadian cannabis retail, we’ll hear from national leaders of successful chains on the pros and cons of being full-service vs. specialized and how to stay agile amid changing legislation, taxation and customer preferences. As new product categories come on stream, learn about cross-sector integration when edibles, beverages, concentrates and topicals. Plus, what can cannabis learn from other sectors such as alcohol?
5:00pm - 7:00pm

Networking Reception

Alex Shiff

Senior Consultant, Navigator

Andrés Fajardo

Co-Founder and Chairman, Clever Leaves

Brian Harriman

President & CEO, Alcool NB Liquor

Cameron Bishop

Canadian Government Affairs Activities, Tilray Inc., Privateer Holdings

Chris Friel

Mayor, City of Brantford

Chuck Rifici

Chairman and CEO, Cannabis Wheaton Income

Dan Sutton

CEO and Founder, Tantalus Labs

Dr. Arup Sen

CEO, Infusion Biosciences

Dr. Danial Schecter

Founder, Cannabinoid Medical Clinic

Dr. Jonathan Page

CEO and Co-Founder, Anandia Labs

Dr. Natasha Ryz

CSO, Zenabis

Eric Costen

Director General, Cannabis Legalization and Regulation Secretariat, Government of Canada

Felicia Snyder

SVP of Growth, Hiku Brands

Hugo Alves

President & Director, Wheaton Income

Jim Carmack

Head of Capital Markets, MedMen Enterprises

John Clare

Director of Policy, Cannabis Legalization Regulation Secretariat, Government of Canada

John Kagia

EVP, Industry Analytics, New Frontier Data

Justin Bates

CEO, Neighbourhood Pharmacy Association of Canada

Loren Padelford

VP, Shopify

Louis Barre

Principal, Cannab Intel Inc.